Cory Kasimov
Stock Analyst at Evercore ISI
(4.83)
# 448
Out of 4,376 analysts
992
Total ratings
56%
Success rate
15.7%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $50 | $25.27 | +97.90% | 1 | May 26, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $56.77 | +111.38% | 83 | May 21, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $200 → $210 | $163.88 | +28.14% | 16 | May 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $875 → $825 | $635.45 | +29.83% | 77 | May 18, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 | $18.58 | +115.29% | 7 | May 13, 2026 | |
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $25 | $10.55 | +137.08% | 1 | May 12, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $55 → $80 | $51.73 | +54.65% | 6 | May 8, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $65 | $44.30 | +46.73% | 1 | May 8, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $125 → $130 | $67.61 | +92.28% | 19 | May 8, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $35 → $45 | $29.40 | +53.06% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $35.59 | +26.44% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.65 | +108.09% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $149.23 | +34.02% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $530 → $535 | $446.83 | +19.73% | 59 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $50 | $47.44 | +5.40% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $303.05 | +31.99% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $14.77 | +130.20% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $71.48 | +11.92% | 10 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.50 | +233.33% | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $7.05 | +112.77% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $17.47 | +214.83% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $88.08 | +47.59% | 31 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $128 | $21.91 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $84 | $17.16 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $42.80 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $221 | $195.34 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $21.56 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $2.68 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $1.88 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $19 → $16 | $2.71 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $227 | $349.58 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $98 → $86 | $102.38 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $32.62 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $16.11 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $129.16 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $7.03 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $81.94 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $49.84 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.47 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.40 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $100 | $1,131.42 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $278.67 | $7.49 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.215 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.28 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $9.08 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $9.49 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $68 | $74.48 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $312.37 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $8.41 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.93 | n/a | 1 | Jun 4, 2013 |
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $25.27
Upside: +97.90%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $56.77
Upside: +111.38%
Neurocrine Biosciences
May 18, 2026
Maintained: Buy
Price Target: $200 → $210
Current: $163.88
Upside: +28.14%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $875 → $825
Current: $635.45
Upside: +29.83%
Immunome
May 13, 2026
Maintained: Buy
Price Target: $40
Current: $18.58
Upside: +115.29%
Benitec Biopharma
May 12, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $10.55
Upside: +137.08%
Xenon Pharmaceuticals
May 8, 2026
Maintained: Buy
Price Target: $55 → $80
Current: $51.73
Upside: +54.65%
Scholar Rock Holding
May 8, 2026
Maintained: Buy
Price Target: $65
Current: $44.30
Upside: +46.73%
BridgeBio Pharma
May 8, 2026
Maintained: Buy
Price Target: $125 → $130
Current: $67.61
Upside: +92.28%
Beam Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $35 → $45
Current: $29.40
Upside: +53.06%
May 8, 2026
Maintained: Buy
Price Target: $45
Current: $35.59
Upside: +26.44%
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $8.65
Upside: +108.09%
May 7, 2026
Maintained: Buy
Price Target: $200
Current: $149.23
Upside: +34.02%
May 5, 2026
Maintained: Buy
Price Target: $530 → $535
Current: $446.83
Upside: +19.73%
May 4, 2026
Maintained: Hold
Price Target: $35 → $50
Current: $47.44
Upside: +5.40%
May 1, 2026
Reiterated: Buy
Price Target: $400
Current: $303.05
Upside: +31.99%
May 1, 2026
Maintained: Buy
Price Target: $34
Current: $14.77
Upside: +130.20%
Apr 1, 2026
Maintained: Buy
Price Target: $80
Current: $71.48
Upside: +11.92%
Apr 1, 2026
Maintained: Buy
Price Target: $25
Current: $7.50
Upside: +233.33%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $7.05
Upside: +112.77%
Mar 17, 2026
Maintained: Buy
Price Target: $55
Current: $17.47
Upside: +214.83%
Mar 11, 2026
Maintained: Buy
Price Target: $130
Current: $88.08
Upside: +47.59%
Jul 29, 2022
Maintained: Buy
Price Target: $126 → $128
Current: $21.91
Upside: n/a
Jul 28, 2022
Maintained: Hold
Price Target: $91 → $84
Current: $17.16
Upside: n/a
Jul 27, 2022
Maintained: Hold
Price Target: $30 → $33
Current: $42.80
Upside: n/a
Jul 20, 2022
Maintained: Hold
Price Target: $219 → $221
Current: $195.34
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $21.56
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $14 → $11
Current: $2.68
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $24 → $20
Current: $1.88
Upside: n/a
May 4, 2022
Maintained: Sell
Price Target: $19 → $16
Current: $2.71
Upside: n/a
Apr 28, 2022
Maintained: Hold
Price Target: $235 → $227
Current: $349.58
Upside: n/a
Feb 9, 2022
Maintained: Hold
Price Target: $98 → $86
Current: $102.38
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $61
Current: $32.62
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $16.11
Upside: n/a
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $129.16
Upside: n/a
Feb 25, 2021
Maintained: Sell
Price Target: n/a
Current: $7.03
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $81.94
Upside: n/a
Nov 13, 2019
Maintained: Buy
Price Target: n/a
Current: $49.84
Upside: n/a
Jun 26, 2018
Maintained: Sell
Price Target: n/a
Current: $0.47
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.40
Upside: n/a
Apr 11, 2017
Maintained: Buy
Price Target: $384 → $100
Current: $1,131.42
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $278.67
Current: $7.49
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.215
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $2.28
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $9.08
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $9.49
Upside: n/a
Jun 8, 2015
Maintained: Hold
Price Target: $65 → $68
Current: $74.48
Upside: n/a
Jan 13, 2015
Maintained: Hold
Price Target: n/a
Current: $312.37
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $8.41
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $29.93
Upside: n/a